LearnGlossaryMarketStocksSuperinvestorsSign in

YI

111, Inc.

Healthcare · $31M market cap

Verdict

We can't put a fair value on YI right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-54.3% a year✗
Sales growth25.2% a year✓
Free cash flow growth-53.7% a year✗
Return on invested capital-16.8%✗

Follow YI

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 23, 2026: no open-market purchases and 1 sale worth $8K. Why purchases matter

Sales

Chen Yang Luke

director · 2026-09-23

Sold

$8K

About 111, Inc.

Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical…

Medical - Distribution

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works